Interventions: A:The first and third cycles were treated with Chinese herbal medicine from the day before chemotherapy to the sixth day, and the second and fourth cycles were treated with placebo from
In this open-label phase II study, patients will be scheduled for neoadjuvant treatment with PD-1 inhibitors (Camrelizumab) plus VEGF inhibitor (Apatinib) for dMMR/MSI-H colorectal cancer staged as lo
